The FDA has extended the review period for the New Drug Application for elamipretide for the treatment of Barth syndrome.

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company today announced the U.S. Food and Drug Administration (FDA) has ac ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

Addresses the significant threat of antimicrobial resistance.

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

The best tablets of 2024 were the new iPad Pro M4 family, Apple's sleek and thin new iPad Pro models. Will 2025 be the year that Android tablets close the gap on Apple's premium tabs? We don't ...

A small tablet can work just as well as (or even better than) larger ones, especially when it comes to lugging one around between classes or in your work bag on your commute. When you're on the ...

TEL AVIV, Israel (AP) — Four female Israeli soldiers who were taken in the attack that sparked the war in Gaza returned to Israel on Saturday after Hamas militants paraded them before a crowd of ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

Apple iPad (10th Generation): with A14 Bionic chip, 27.69 cm (10.9″) Liquid Retina Display, 64GB, Wi-Fi 6, 12MP front/12MP Back Camera, Touch ID, All-Day Battery Life – Blue View Details ...